Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00478452
What this trial is testing

Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
University of Pennsylvania 14
Testing effectiveness (Phase 2)Study completedNCT01891344
What this trial is testing

Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 491
Testing effectiveness (Phase 2)Ended earlyNCT03824704
What this trial is testing

Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more
pharmaand GmbH 1
Large-scale testing (Phase 3)Study completedNCT00262847
What this trial is testing

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+24 more
National Cancer Institute (NCI) 1,873
Early research (Phase 1)Study completedNCT00003385
What this trial is testing

Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 48
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Not applicableLooking for participantsNCT05236686
What this trial is testing

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 94
Testing effectiveness (Phase 2)Study completedNCT00112957
What this trial is testing

Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Ludwig Institute for Cancer Research 23
Large-scale testing (Phase 3)Looking for participantsNCT04111978
What this trial is testing

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

Who this might be right for
Ovarian Neoplasm EpithelialFallopian Tube NeoplasmsPeritoneal Neoplasms+3 more
Swiss GO Trial Group 540
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712
What this trial is testing

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more
National Cancer Institute (NCI) 692
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT01329549
What this trial is testing

Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)

Who this might be right for
Ovarian Neoplasms
Boehringer Ingelheim 2
Not applicableStudy completedNCT01832415
What this trial is testing

First Line Ovarian Cancer Treatment - Cohort Study

Who this might be right for
Epithelial Ovarian Cancer
ARCAGY/ GINECO GROUP 500
Testing effectiveness (Phase 2)Study completedNCT03480750
What this trial is testing

Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms Malignant (Excl Germ Cell)Peritoneal CarcinomaFallopian Tube Cancer
National Cheng-Kung University Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT03312114
What this trial is testing

Anti-PD-L1 and SAbR for Ovarian Cancer

Who this might be right for
Recurrent Epithelial Cancer of OvaryPrimary Peritoneal CarcinomaFallopian Tube Cancer
University of Texas Southwestern Medical Center 5
Early research (Phase 1)Study completedNCT00526617
What this trial is testing

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Who this might be right for
Non-hematologic MalignanciesMetastatic MelanomaBreast Cancer+4 more
AbbVie 41
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Ended earlyNCT02641639
What this trial is testing

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian Cancer
Mateon Therapeutics 70
Early research (Phase 1)Ended earlyNCT05200364
What this trial is testing

STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian CarcinomaOvary Cancer+2 more
Sutro Biopharma, Inc. 58
Large-scale testing (Phase 3)Ended earlyNCT03642132
What this trial is testing

Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

Who this might be right for
Ovarian Cancer
Pfizer 79
Next Page